Cargando…
Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab
Drug development is a lengthy, costly process with low probability of success. Biopharmaceuticals are highly specific molecules, with efficacy and safety closely tied to target biology and pharmacology. The “learning−predicting−confirming” continuum by translational and clinical modeling and simulat...
Autores principales: | Wang, Bing, Wu, Chi‐Yuan, Jin, Denise, Vicini, Paolo, Roskos, Lorin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784736/ https://www.ncbi.nlm.nih.gov/pubmed/28836356 http://dx.doi.org/10.1002/psp4.12245 |
Ejemplares similares
-
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
por: Jones, HM, et al.
Publicado: (2013) -
Step‐by‐step comparison of ordinary differential equation and agent‐based approaches to pharmacokinetic‐pharmacodynamic models
por: Truong, Van Thuy, et al.
Publicado: (2022) -
Teaching Targeted Drug Discovery and Development to Healthcare Professionals
por: Fruchter, Renee, et al.
Publicado: (2017) -
Machine Learning in Drug Discovery and Development Part 1: A Primer
por: Talevi, Alan, et al.
Publicado: (2020) -
A Model‐Informed Drug Discovery and Development Strategy for the Novel Glucose‐Responsive Insulin MK‐2640 Enabled Rapid Decision Making
por: Visser, Sandra A.G., et al.
Publicado: (2020)